News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Jonathan Licht: How KDM6A controls MHC-I and II expression in multiple myeloma cells
Jonathan Licht/X
Oct 9, 2024, 16:24

Jonathan Licht: How KDM6A controls MHC-I and II expression in multiple myeloma cells

Jonathan Licht, Director of the UF Health Cancer Center, shared a post on X:

“Our paper on how tumor suppressor KDM6A controls MHC-I and II expression in multiple myeloma cells is out in print in Blood Journal.

KDM6A loss can be ameliorated by treatment of cells with an HDAC3 inhibitor, restoring MHC expression.”

KDM6A controls immunogenicity in MM

Authors: Jerome Moreaux.

Jonathan Licht: How KDM6A controls MHC-I and II expression in multiple myeloma cells

 

Blood Journal cancer cancer awareness cancer care Cancer research fight against cancer Global fight against cancer Jerome Moreaux Jonathan Licht Myeloma OncoDaily Oncology
Special Coverage
Insight
Oct 9, 2024, 16:24
Jonathan Licht: How KDM6A controls MHC-I and II expression in multiple myeloma cells
Blog
Oct 9, 2024, 16:19
Anxiety and depression management for cancer patients - Society for Integrative Oncology
Dialogues
Oct 9, 2024, 16:12
Dr. Susanna Greer: Advancing Cancer Research at the V Foundation | OncoInfluencers
Blog
Oct 9, 2024, 16:09
Ribbon-cutting ceremony in EMD Serono's headquarters in the Seaport district - Merck Healthcare
OncoDaily Pulse
Oct 9, 2024, 16:03
Inside OncoDaily Party Barcelona
Blog
Oct 9, 2024, 15:55
Amol Akhade: Perioperative chemo vs CTRT in GE Junction and Gastric Adenocarcinoma
Blog
Oct 9, 2024, 15:45
Victor R. Ambros to share the 2024 Nobel Prize in Physiology or Medicine for his co-discovery of microRNA - UMass Chan Medical School
Blog
Oct 9, 2024, 15:40
Tanja Obradovic: Orum Therapeutics is focusing its innovation pipeline on degrader-antibody conjugates
Blog
Oct 9, 2024, 15:31
Manaaki Health Care and ESHO have signed a MOU to advance cancer care in Ethiopia
Blog
Oct 9, 2024, 15:29
A collaboration between MiNK Therapeutics and Autonomous Therapeutics
Blog
Oct 9, 2024, 15:23
Cihan Gani: Comprehensive Motion Management for MR-Linac
Blog
Oct 9, 2024, 15:23
Upal Basu Roy: How immune cells can be engineered to target EGFR+ NSCLC